间充质干细胞、其衍生因子及细胞外囊泡在肝衰竭中的作用
Role of mesenchymal stem cells, their derived factors, and extracellular vesicles in liver failure.
作者信息
Wang Jie, Cen Panpan, Chen Jiajia, Fan Linxiao, Li Jun, Cao Hongcui, Li Lanjuan
机构信息
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University, 79 Qingchun Road, Hangzhou, 310006, China.
出版信息
Stem Cell Res Ther. 2017 Jun 6;8(1):137. doi: 10.1186/s13287-017-0576-4.
Abstract
Liver failure is a severe clinical syndrome with a poor prognosis. Mesenchymal stem cell (MSC) transplantation has emerged as a new intervention in treating liver failure. It is conventionally recognized that MSCs exert their therapeutic effect mainly through transdifferentiation. Recently, published articles have shown that MSCs work in liver failure by secreting trophic and immunomodulatory factors as well as extracellular vesicles (EVs) before transdifferentiation. In particular,MSC-derived EVs have shown similar curative effects as MSCs. Here we review the role of MSCs as well as their derived factors and EVs in liver failure and discuss the use of MSC-derived EVs instead of intact MSCs in treating liver failure.
摘要
肝衰竭是一种预后较差的严重临床综合征。间充质干细胞（MSC）移植已成为治疗肝衰竭的一种新干预措施。传统上认为，间充质干细胞主要通过转分化发挥其治疗作用。最近，已发表的文章表明，间充质干细胞在转分化之前通过分泌营养和免疫调节因子以及细胞外囊泡（EVs）来治疗肝衰竭。特别是，源自间充质干细胞的细胞外囊泡已显示出与间充质干细胞相似的治疗效果。在此，我们综述了间充质干细胞及其衍生因子和细胞外囊泡在肝衰竭中的作用，并讨论了使用源自间充质干细胞的细胞外囊泡而非完整的间充质干细胞来治疗肝衰竭。
相似文献
1
Role of mesenchymal stem cells, their derived factors, and extracellular vesicles in liver failure.间充质干细胞、其衍生因子及细胞外囊泡在肝衰竭中的作用
Stem Cell Res Ther. 2017 Jun 6;8(1):137. doi: 10.1186/s13287-017-0576-4.
2
Human bone marrow mesenchymal stem cell-derived extracellular vesicles attenuate neuroinflammation evoked by focal brain injury in rats.人骨髓间充质干细胞来源的细胞外囊泡减轻大鼠局灶性脑损伤引起的神经炎症。
J Neuroinflammation. 2019 Nov 13;16(1):216. doi: 10.1186/s12974-019-1602-5.
3
Mesenchymal Stromal Cell-Derived Extracellular Vesicles Protect the Fetal Brain After Hypoxia-Ischemia.间充质基质细胞衍生的细胞外囊泡在缺氧缺血后保护胎儿大脑。
Stem Cells Transl Med. 2016 Jun;5(6):754-63. doi: 10.5966/sctm.2015-0197. Epub 2016 May 9.
4
Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations.人骨髓间充质基质/干细胞衍生的细胞外囊泡减轻移植物抗宿主病与外周血幼稚 T 细胞群体的保存有关。
Stem Cells. 2018 Mar;36(3):434-445. doi: 10.1002/stem.2759. Epub 2017 Dec 27.
5
Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression.细胞外囊泡可改善中风后的神经再生并预防缺血后免疫抑制。
Stem Cells Transl Med. 2015 Oct;4(10):1131-43. doi: 10.5966/sctm.2015-0078. Epub 2015 Sep 3.
6
Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?间充质干细胞衍生的细胞外囊泡：在造血移植中发挥作用？
Int J Mol Sci. 2017 May 9;18(5):1022. doi: 10.3390/ijms18051022.
7
Effects of Extracellular Vesicles Derived from Mesenchymal Stem/Stromal Cells on Liver Diseases.细胞外囊泡衍生的间充质干细胞对肝脏疾病的影响。
Curr Stem Cell Res Ther. 2019;14(5):442-452. doi: 10.2174/1574888X14666190308123714.
8
Extracellular vesicles released from mesenchymal stromal cells stimulate bone growth in osteogenesis imperfecta.间质基质细胞释放的细胞外囊泡可刺激成骨不全症中的骨生长。
Cytotherapy. 2018 Jan;20(1):62-73. doi: 10.1016/j.jcyt.2017.09.012. Epub 2017 Oct 26.
9
Bone marrow mesenchymal stem cells reduce ureteral stricture formation in a rat model via the paracrine effect of extracellular vesicles.骨髓间充质干细胞通过细胞外囊泡的旁分泌作用减少大鼠模型中的输尿管狭窄形成。
J Cell Mol Med. 2018 Sep;22(9):4449-4459. doi: 10.1111/jcmm.13744. Epub 2018 Jul 11.
10
Application of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Stroke: Biodistribution and MicroRNA Study.间充质干细胞衍生的细胞外囊泡在脑卒中治疗中的应用：生物分布和 microRNA 研究。
Transl Stroke Res. 2019 Oct;10(5):509-521. doi: 10.1007/s12975-018-0668-1. Epub 2018 Oct 19.
引用本文的文献
1
Dexamethasone-boosted mesenchymal stem cell secretome: insight into hepatic protection.地塞米松增强的间充质干细胞分泌组：对肝脏保护的见解。
BMC Biotechnol. 2025 Jun 4;25(1):44. doi: 10.1186/s12896-025-00980-8.
2
Mesenchymal stem cells therapy for acute liver failure: Recent advances and future perspectives.间充质干细胞治疗急性肝衰竭：最新进展与未来展望
Liver Res. 2021 Mar 31;5(2):53-61. doi: 10.1016/j.livres.2021.03.003. eCollection 2021 Jun.
3
Controlled release of hydrogel-encapsulated mesenchymal stem cells-conditioned medium promotes functional liver regeneration after hepatectomy in metabolic dysfunction-associated steatotic liver disease.水凝胶包封间充质干细胞条件培养基的控释促进代谢相关脂肪性肝病肝功能障碍性肝切除术后的功能性肝再生。
Stem Cell Res Ther. 2024 Nov 4;15(1):395. doi: 10.1186/s13287-024-03993-w.
4
Role of connexin 32 in the directional differentiation of induced pluripotent stem cells into hepatocytes.连接蛋白 32 在诱导多能干细胞定向分化为肝细胞中的作用。
Int J Med Sci. 2024 Jan 12;21(3):508-518. doi: 10.7150/ijms.83973. eCollection 2024.
5
Protective role of stem cells in POI: Current status and mechanism of action, a review article.干细胞在原发性卵巢功能不全中的保护作用：现状与作用机制，一篇综述文章
Heliyon. 2023 Dec 6;10(1):e23271. doi: 10.1016/j.heliyon.2023.e23271. eCollection 2024 Jan 15.
6
Bio-Inspired Nanocarriers Derived from Stem Cells and Their Extracellular Vesicles for Targeted Drug Delivery.源自干细胞及其细胞外囊泡的仿生纳米载体用于靶向药物递送
Pharmaceutics. 2023 Jul 24;15(7):2011. doi: 10.3390/pharmaceutics15072011.
7
Acute liver failure: A systematic review and network meta-analysis of optimal type of stem cells in animal models.急性肝衰竭：动物模型中最佳干细胞类型的系统评价和网状Meta分析
World J Stem Cells. 2023 Jan 26;15(1):1-15. doi: 10.4252/wjsc.v15.i1.1.
8
Advance of Mesenchymal Stem Cells in Chronic End-Stage Liver Disease Control.间充质干细胞在慢性终末期肝病控制中的研究进展
Stem Cells Int. 2022 Oct 7;2022:1526217. doi: 10.1155/2022/1526217. eCollection 2022.
9
Stem cell transplantation for treating liver diseases: progress and remaining challenges.干细胞移植治疗肝脏疾病：进展与尚存挑战
Am J Transl Res. 2021 May 15;13(5):3954-3966. eCollection 2021.
10
Extracellular Vesicles from Mesenchymal Stromal Cells for the Treatment of Inflammation-Related Conditions.间充质基质细胞来源的细胞外囊泡治疗炎症相关疾病。
Int J Mol Sci. 2021 Mar 16;22(6):3023. doi: 10.3390/ijms22063023.
本文引用的文献
1
Exosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failure.源自人月经血干细胞的外泌体可缓解暴发性肝衰竭。
Stem Cell Res Ther. 2017 Jan 23;8(1):9. doi: 10.1186/s13287-016-0453-6.
2
hucMSC Exosome-Derived GPX1 Is Required for the Recovery of Hepatic Oxidant Injury.人脐带间充质干细胞外泌体来源的谷胱甘肽过氧化物酶1是肝脏氧化损伤恢复所必需的。
Mol Ther. 2017 Feb 1;25(2):465-479. doi: 10.1016/j.ymthe.2016.11.019. Epub 2017 Jan 6.
3
Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery.小包裹里有好东西：克服挑战，利用细胞外囊泡进行治疗性递药。
J Control Release. 2016 Nov 10;241:174-185. doi: 10.1016/j.jconrel.2016.09.016. Epub 2016 Sep 22.
4
Extracellular vesicles: masters of intercellular communication and potential clinical interventions.细胞外囊泡：细胞间通讯的掌控者及潜在的临床干预手段
J Clin Invest. 2016 Apr 1;126(4):1139-43. doi: 10.1172/JCI87316.
5
Exosomes as therapeutics: The implications of molecular composition and exosomal heterogeneity.外泌体作为治疗手段：分子组成和外泌体异质性的影响。
J Control Release. 2016 Apr 28;228:179-190. doi: 10.1016/j.jconrel.2016.02.037. Epub 2016 Mar 2.
6
Quantitative evaluation of human bone mesenchymal stem cells rescuing fulminant hepatic failure in pigs.定量评估人骨髓间充质干细胞对猪暴发性肝衰竭的修复作用。
Gut. 2017 May;66(5):955-964. doi: 10.1136/gutjnl-2015-311146. Epub 2016 Feb 16.
7
Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells.全身应用的间充质干/基质细胞的生物分布、迁移及归巢
Stem Cell Res Ther. 2016 Jan 11;7:7. doi: 10.1186/s13287-015-0271-2.
8
The Therapeutic Promise of Mesenchymal Stem Cells for Liver Restoration.间充质干细胞在肝脏修复中的治疗潜力。
Trends Mol Med. 2015 Nov;21(11):673-686. doi: 10.1016/j.molmed.2015.09.004. Epub 2015 Oct 22.
9
Therapeutic Potential of Multipotent Mesenchymal Stromal Cells and Their Extracellular Vesicles.多能间充质基质细胞及其细胞外囊泡的治疗潜力
Hum Gene Ther. 2015 Aug;26(8):506-17. doi: 10.1089/hum.2015.072. Epub 2015 Aug 3.
10
Stem Cell Therapies in Clinical Trials: Progress and Challenges.临床试验中的干细胞疗法：进展与挑战。
Cell Stem Cell. 2015 Jul 2;17(1):11-22. doi: 10.1016/j.stem.2015.06.007.
Zotero 插件